Grew 56% to $102.5 million for the year; Q4 adjusted operating income was $17.6 million. Adjusted Operating Margin -- ...

Anyone who has ever cared for a baby will no doubt have wondered what’s going on inside their little heads. With only “crying” and “not crying” as options for communication, at least when they’re very ...

Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas ASCO Guidelines ...

Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0 This guideline consolidates all previous updates and reflects the body of evidence informing ...